Doxapram hydrochloride anhydrous

Contains different amounts of anhydride.

Contains different amounts of anhydride.

1-Naphthaleneacetic anhydride.

1-Naphthaleneacetic anhydride.

1-Naphthaleneacetic anhydride.

Application 1400W dihydrochloride has been used: as a strong inhibitor of inducible nitric oxide to analyse its effect on intestinal ischemia/reperfusion (I/R) injury model in rat as inducible nitric oxide synthase (iNOS)-selective inhibitor,

2,4,6-Trifluorophenol is a trihalogenated phenol, which is a substrate for the enzyme, dehaloperoxidase (DHP). It is known that DHP is a dual-function protein that displays elements of both hemoglobins and peroxidases. Studies indicate that DHP has

2,4,6-Trifluorophenol is a trihalogenated phenol, which is a substrate for the enzyme, dehaloperoxidase (DHP). It is known that DHP is a dual-function protein that displays elements of both hemoglobins and peroxidases. Studies indicate that DHP has

2,4,6-Trifluorophenol is a trihalogenated phenol, which is a substrate for the enzyme, dehaloperoxidase (DHP). It is known that DHP is a dual-function protein that displays elements of both hemoglobins and peroxidases. Studies indicate that DHP has

Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung

Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung

Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung